Cryptococcus infection:
An emerging global threat to human health
250K
yearly cases of infection among only HIV+ patients with significant mortality rates (41-61%).
19%
of all HIV-related deaths are linked to cryptococcal infections.
2x
increase in Europe & North America cases since 2009.
#1
fungal pathogen of concern (World Health Organization) with emerging drug resistance.
"Antifungals are usually broad spectrum – that’s a problem driving the resistance crisis in Cryptococcus infections. NeoPeptix is NuvoBio’s peptide-based narrow spectrum solution."
Curious About NeoPeptix?
Reach Out to Us for a Chat and Discover More!